Stockreport

Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives [Yahoo! Finance]

Ventyx Biosciences, Inc.  (VTYX) 
PDF As of December 18, 2025, 90% of analysts are bullish on Ventyx Biosciences, Inc. (NASDAQ:VTYX), setting a median price target of $14.00. This translates into a massive [Read more]